Skip to main content
SpringerLink
Log in

Nuclear Oncology

  • Chapter
  • First Online:
A Concise Guide to Nuclear Medicine

  • 1120 Accesses

Abstract

Nuclear medicine has a major role in the management of malignant tumors. With the developments toward molecular imaging and the advancement of equipment used for imaging particularly after combining the nuclear medicine instruments with morphologic modalities, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Additionally sentinel node identification and localization for biopsy is another important use of nuclear medicine to help plan the most suitable management for several tumors. The main tumor imaging radiopharmaceutical can be summarized as shown in Table 10.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Bahl S, Alavi A, Basu S, Czerniecki BJ (2009) The role of PET and PET/CT in the surgical management of breast cancer: a review. PET Clin 4:277–287

    Article  Google Scholar 

  • Eubank WB, Lee JH, Mankoff DA (2009) Disease restaging and diagnosis of recurrent and metastatic disease following primary therapy with FDG-PET imaging. PET Clin 4:299–312

    Article  PubMed  Google Scholar 

  • Francis IR, Brown RKJ, Avram AM (2005) The clinical role of CT/PET in oncology: an update. Cancer Imaging 5:S68–S75

    Article  PubMed  Google Scholar 

  • Jana S, Abdel-Dayem HM (2006) Basis of tumor imaging; scintigraphic and pathophysiologic correlation. In: Elgazzar AH (ed) Pathophysiologic basis of nuclear medicine, 2nd edn. Springer, Berlin-New York

    Google Scholar 

  • Roses RE, Kumar R, Alavi A, Czerniecki BJ (2009) The role of lymphatic mapping and sentinel lymph node biopsy in the staging of breast cancer. PET Clin 4:265–276

    Article  Google Scholar 

  • Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T (2006) Glut-1 expression and enhanced glucose metabolism are associated with tumor grade in bone and soft tissue. Eur J Nucl Med Mol Imaging 33:683–691

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kuwait, Kuwait

    Abdelhamid H. Elgazzar MD., FCAP

Authors
  1. Abdelhamid H. Elgazzar MD., FCAP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdelhamid H. Elgazzar MD., FCAP .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Elgazzar, A.H. (2011). Nuclear Oncology. In: A Concise Guide to Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19426-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19426-9_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19425-2

  • Online ISBN: 978-3-642-19426-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation